Reproducibility of MDM2 and CDK4 staining in soft tissue tumors

American Journal of Clinical Pathology

Volumn 125, Issue 5, 2006, Pages 693-697

  Binh, Matthieu Bui Nguyen ^a   Garau, Xavier Sastre ^b   Guillo, Louis ^c   Aurias, Alain ^b   Coindre, Jean Michel ^a  

^a INSTITUT BERGONIÉ   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

CDK4; Immunohistochemistry; MDM2; Reproducibility; Sarcoma; Tissue microarray

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2;

ANGIOSARCOMA; ARTICLE; CLINICAL LABORATORY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; TISSUE MICROARRAY; TUMOR DIAGNOSIS;

EID: 33646234217     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/VMBP67QUNN6Q3J0E     Document Type: Article

References (19)

1. McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.
2. Stephenson CF, Berger CS, Leong SP, et al. Analysis of a giant marker chromosome in a well-differentiated liposarcoma using cytogenetics and fluorescence in situ hybridization. Cancer Genet Cytogenet. 1992;61:134-138.
3. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 1993;68:85-90.
4. Pedeutour F, Suijkerbuijk RF, Van Gaal J, et al. Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma [letter]. Cancer Genet Cytogenet. 1993;66:133-134.
5. Pedeutour F, Suijkerbuijk RF, Forus A, et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer. 1994;10:85-94.
6. Bui Nguyen Binh M, Sastre X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 561 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347.
7. Fletcher CDM, Unni K, Mertens M, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Oxford University Press; 2004. World Health Organization Classification of Tumours.
8. Nilbert M, Engellau J. Experiences from tissue microarray in soft tissue sarcomas. Acta Orthop Scand Suppl. 2004;75:29-34.
9. Vincent-Salomon A, MacGrogan G, Couturier J, et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS Study. Histopathology. 2003;42:337-347.
10. Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database. Nucleic Acids Res. 1998;26:3453-3459.
11. Watanabe T, Ichikawa A, Saito H, et al. Overexpression of the MDM2 oncogene in leukemia and lymphoma. Leuk Lymphoma. 1996;21:391-397.
12. McInnes C, Wang S, Anderson S, et al. Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors. Chem Biol. 2004;11:525-534.
13. Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004;303:844-848.
14. von Wasielewski R, Mengel M, Wiese B, et al. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol. 2002;118:675-682.
15. Mengel M, von Wasielewski R, Wiese B, et al. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol. 2002;198:292-299.
16. Hsu CY, Ho DM, Yang CF, et al. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods. Mod Pathol. 2003;16:951-957.
17. Hsu CY, Ho DM, Yang CF, et al. Interobserver reproducibility of HER-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest. Am J Ciin Pathol. 2002;118:693-698.
18. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 2001;158:1245-1251.
19. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943-1949.